Body mass index and additional risk factors for cancer in adults with cystic fibrosis.

Autor: Knotts RM; Division of Gastroenterology and Hepatology, New York University Langone Health, New York University School of Medicine, New York, NY, USA. rita.knotts@nyulangone.org.; 240 E38 Street, 23rd Floor, New York, NY, 10016, USA. rita.knotts@nyulangone.org., Jin Z; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA., Doyle JB; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Keating C; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., DiMango E; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Abrams JA; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Publikováno v: Cancer causes & control : CCC [Cancer Causes Control] 2022 Dec; Vol. 33 (12), pp. 1445-1451. Date of Electronic Publication: 2022 Sep 30.

Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease.

Autor: Hung KW; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York; Section of Digestive Diseases, Department of Medicine, Yale University, New Haven, Connecticut. Electronic address: kenneth.hung@yale.edu., Knotts RM; Division of Gastroenterology and Hepatology, Department of Medicine, New York University, New York, New York., Faye AS; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York., Pont AR; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York., Lebwohl B; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York., Abrams JA; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York., Freedberg DE; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, New York; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 May; Vol. 18 (5), pp. 1091-1098.e1. Date of Electronic Publication: 2019 Jul 25.

SYNTHESIS OF RHENANITE (beta-NaCaPO4)-APATITIC CALCIUM PHOSPHATE BIPHASICS FOR SKELETAL REPAIR

Autor: Knotts, RM, Jalota, S, Bhaduri, SB, Tas, AC

Biphasic rhenanite (beta-NaCaPO4)-apatitic calcium phosphate biomaterials for skeletal repair were prepared by using a one-pot, solution-based synthesis procedure at the physiological pH of 7.4, followed by low-temperature (300 degrees to 600 degrees

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10007::0565cd435b7f23d859c4b96371be005d
https://hdl.handle.net/20.500.11831/6589

Cystic fibrosis is associated with an increased risk of Barrett's esophagus.

Autor: Knotts RM; Division of Gastroenterology, NYU Langone Health, NYU School of Medicine, New York, NY, USA. Electronic address: rita.knotts@nyumc.org., Solfisburg QS; Division of Digestive & Liver Diseases, Columbia University Medical Center, New York, NY, USA., Keating C; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University, New York, NY, USA., DiMango E; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University, New York, NY, USA., Lightdale CJ; Division of Digestive & Liver Diseases, Columbia University Medical Center, New York, NY, USA., Abrams JA; Division of Digestive & Liver Diseases, Columbia University Medical Center, New York, NY, USA.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2019 May; Vol. 18 (3), pp. 425-429. Date of Electronic Publication: 2018 Nov 23.

A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing.

Autor: Omecene NE; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA., Wilcox N; Department of Pharmacy, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA., Cox AL; Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA., Ham P; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA., Ong R; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA., Barber AT; Division of Pediatric Pulmonary and Sleep Medicine, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA., Zimmerman KM; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.

Publikováno v: Pediatric pulmonology [Pediatr Pulmonol] 2024 Dec; Vol. 59 (12), pp. 3148-3158. Date of Electronic Publication: 2024 Aug 28.